Effectiveness of long-term hormone therapy for endometriosis after surgical treatment
- Autores: Bezhenar V.F.1, Kruglov S.Y.1, Kuzmina N.S.1, Krylova Y.S.1, Sergienko A.S.1, Abilbekova A.K.1, Zhemchuzhina T.Y.1
-
Afiliações:
- I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
- Edição: Nº 4 (2021)
- Páginas: 134-142
- Seção: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/249263
- DOI: https://doi.org/10.18565/aig.2021.4.134-142
- ID: 249263
Citar
Texto integral
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Texto integral
Sobre autores
Vitaly Bezhenar
I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Email: bez-vitaly@yandex.ru
Dr. Med. Sci., professor, Head of the Departments of Obstetrics, Gynecology and Neonatology/Obstetrics, Gynecology and Reproductology
Sergey Kruglov
I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Email: skruglov89@mai.ru
PhD, Assistant of the Department of Obstetrics, Gynecology and Reproductology
Natalya Kuzmina
I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Email: dok.kuzmina@gmail.com
PhD, Assistant of the Department of Obstetrics, Gynecology and Neonatology, Head of the Department of Oncology No. 7 (Oncogynecology) of the Clinic of Obstetrics and Gynecology
Yulia Krylova
I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of RussiaPhD, Assistant of the Department of Pathological Anatomy with the Pathological Department
Alina Sergienko
I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Email: md.sergienko@gmail.com
postgraduate student of the Department of Obstetrics, Gynecology and Reproductology
Ainur Abilbekova
I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Email: ainur.abilbekova@yahoo.com
postgraduate student of the Department of Obstetrics, Gynecology and Reproductology
Tatyana Zhemchuzhina
I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Email: tzhemchuzhina@mail.ru
PhD, Associate Professor of the Department of Obstetrics, Gynecology and Reproductology
Bibliografia
- Vercellini P., Buggio L, Frattaruolo M.P., Borghi A., Dridi M., Somigliana E. Medical treatment of endometriosis-related pain. Best Pract. Res. Clin. Obstet. Gynecol. 2018; 51: 68-91. https://dx.doi.org/10.1016/ j.bpobgyn.2018.01.015.
- БеженарьВ.Ф., КругловС.Ю., АракелянБ.В.,КузьминаН.С.,Паластин П.М., Крылова Ю.С. Нервсберегающие операции при глубоком инфильтративном эндометриозе. Доктор.Ру. 2019; 7: 40-5. https://dx.doi.org/10.31550/1727-2378-2019-162-7-40-45.
- Dunselman G.A.J., Vermeulen N., Becker C., Calhaz-JKorge C., DHooghe T., De Bie B. et al. ESHRE guideline: management of women with endometriosis. Hum. Reprod. 2014; 29(3): 400-12. https://dx.doi.org/10.1093/humrep/ det457.
- Министерство здравоохранения Российской Федерации. Клинические рекомендации. Эндометриоз. М.; 2016. ID: КР259. Available at: http:// cr.rosminzdrav.ru/#!/recomend/182 [Endometriosis. Clinical guidelines. 2016. ID: KR259. Access from the website of the Ministry of Health of the Russian Federation: http://cr.rosminzdrav.ru/#!/recomend/182 (checked 28.03.2018) (in Russian)].
- Дубровина С.О., Беженарь В.Ф., ред. Эндометриоз. Патогенез, диагностика, лечение. М.: ГЭОТАР-Медиа; 2020. 352 с. [Dubrovina S.O., Bezhenar V.F., eds. Endometriosis, Pathogenesis, diagnosis, treatment. Moscow: GEOTAR-Media, 2020. 352 p. (in Russian)].
- Trivedi P., Selvaraj K., Mahapatra P.D., Srivastava S., Malik S. Effective post-laparoscopic treatment of endometriosis with dydrogesterone. Gynecol. Endocrinol. 2007; 23(Suppl. 1): 73-6. https://dx.doi. org/10.1080/09513590701669583.
- Дубровина С.О., Берлим Ю.Д. Гестагены в терапии эндометрио за. Акушерство и гинекология. 2018; 5: 150-5. [Dubrovina S.O., Berlim Yu.D. Gestagens in the therapy of endometriosis. Obstetrics and gynecology. 2018; 5: 150-5. (in Russian)]. https://dx.doi.org/10.18565/ aig.2018.5.150-155.
- Сухих Г.Т., Адамян Л.В., Козаченко А.В., Дубровина С.О., Баранов И.И., Радзинский В.Е. и др. Дидрогестерон для лечения подтвержденного эндометриоза: ключевые результаты наблюдательного открытого многоцентрового исследования в условиях реальной клинической практики (исследование ОРХИДЕЯ). Акушерство и гинекология: новости, мнения, обучение. 2020; 8(4): 79-81. [Sukhikh G.T., Adamyan L.V., Kozachenko A.V., Dubrovina S.O., Baranov I.I., Radzinsky V.E. et al. Dydrogesterone for the treatment of confirmed endometriosis: key results of an observational open multicenter study in real clinical practice (ORCHIDEA study). Obstetrics and gynecology: news, opinions, training. 2020; 8(4): 79-81. (in Russian)]. https:// dx.doi.org/10.24411/2303-9698-2020-14006.
- Подзолкова Н.М., Татарчук Т.Ф., Дощанова А.М., Ешимбетова Г.З., Сумятина Л.В. Нормализация менструального цикла дидрогестероном. Акушерство и гинекология. 2018; 6: 70-6. [Podzolkova N.M., Tatarchuk T.F., Doschanova A.M., Eshimbetova G.Z., Sumyatina L.V. Dydrogesterone treatment for menstrual-cycle regularization. Obstetrics and gynecology. 2018; 6: 70-6 (in Russian)]. https://dx.doi.org/10.18565/ aig.2018.6.70-76.
- Tournaye H., Sukhikh G.T., Kahler E., Griesinger G. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum. Reprod. 2017; 32(5): 1019-27. https://dx.doi. org/10.1093/humrep/dex023.
- Backer M.H. Jr. Isopregnenone (Duphaston): a new progestational agent. Obstet. Gynecol, 1962; 19: 724-9.
- Johnston W.I.H. Dydrogesterone and endometriosis. BJOG. 1976; 83: 77-80.
- Kaiser E., Wagner Th.A. Die Behandlung der Endometriose mit Dydrogesteron. TW Gynakologie. 1989; 2: 386-8.
- Makhmudova G.M., Gafarova D.Kh., Nazhmutdinova D.K., Lukmanova L.D. Efficacy of duphaston treatment in women with endometriosis after reconstructive surgery. Akush. Ginekol. (Sofiia). 2003; 42(4): 42-6.
- Pandian R.U. Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas. 2009; 65(Suppl. 1): S47
- -50. https://dx.doi.org/10.1016/j.maturitas.2009.11.016.
- Trivedi N., Chauhan N., Vaidya V. Effectiveness and safety of dydrogesterone in regularization of menstrual cycle: a post-marketing study. Gynecol. Endocrinol. 2016: 32(8): 667-71. https://dx.doi.org/10.3109/09513590.2016.1152238.
- Taniguchi F., Ota I., Iba Y., Toda T., Tagashira Y., Ohata Y. et al. The efficacy and safety of dydrogesterone for treatment of dysmenorrhea: An open-label multicenter clinical study. J. Obstet. Gynaecol. Res. 2019; 45(1): 168-75. https://dx.doi.org/10.1111/jog.13807.
- Balasch J., Vanrell J., Marquez M., Gonzalez-Merlo J. Dehydrogesterone treatment of endometrial luteal phase deficiency after ovulation induced by clomiphene citrate and human chorionic gonadotropin. Fertil. Steril. 1983; 40(4): 469-71. https://dx.doi.org/10.1016/ s0015-0282(16)47356-5.
- Савельева Г.М., Сухих Г.Т., Серов В.Н., Манухин И.Б., Радзинский В.Е., ред. Гинекология. Национальное руководство. 2-е изд. М.: ГЭОТАР-Медиа; 2017. 1048 с. [Savelyeva G.M., Sukhikh G.T., Serov V.N., Manukhin I.B., Radzinsky V.E., ed. Gynecology. National guideline. 2nd ed. Moscow: GEOTAR-Media, 2017. 1048 p. (in Russian)].
- Schweppe K.W. The place of dydrogesterone in the treatment of endometriosis and adenomyosis. Maturitas. 2009; 65(Suppl. 1): S23-7. https://dx.doi. org/10.1016/j.maturitas.2009.11.011.
- Инструкция по медицинскому применению препарата Дюфастон® Ссыллка активна на: 06.07.2020. [Instruction on the medical use of the drug Dufaston® Accessed 06.07.2020. (in Russian)].
- Ryder T., Mobberley M., Whitehead M. The endometrial nucleolar channel system as an indicator of progestin potency in HRT. Maturitas. 1995; 22(1): 31-6. https://dx.doi.org/10.1016/0378-5122(95)00912-5.
- Pallacks C., Hirchenhain J., Krussel J.S., Fehm T.N., Fehr D. Endometriosis doubles odds for miscarriage in patients undergoing IVF or ICSI. Eur. J. Obstet. Gynecol. Reprod. Biol. 2017; 213: 33-8. https://dx.doi.org/10.1016/j. ejogrb.2017.04.008.
- Santulli P., Marcellin L., Menard S., Thubert T., Khoshnood B., Gayet V. et al. Increased rate of spontaneous miscarriages in endometriosis-affected women. Hum. Reprod. 2016; 31(5): 1014-23. https://dx.doi.org/10.1093/humrep/ dew035.
- Nickkho-Amiry M., Savant R., Majumder K., Edi-O’sagie E., Akhtar M. The effect of surgical management of endometrioma on the IVF/ ICSI outcomes when compared with no treatment? A systematic review and meta-analysis. Arch. Gynecol. Obstet. 2018; 297(4): 1043-57. https://dx.doi.org/10.1007/ s00404-017-4640-1.
- Carp H.J.A. Progestogens and pregnancy loss. Climacteric. 2018; 21(4): 380-4. https://dx.doi.org/10.1080/13697137.2018.1436166.
- Guideline of the European Society of Human Reproduction and Embryology (ESHRE). Recurrent pregnancy loss. Available at: https://www.eshre.eu/ Guidelines-and-Legal/Guidelines/Recurrent-pregnancy loss.aspx Accessed June 11, 2018.
- Toth B., Wurfel W., Bohlmann M., Zschocke J., Rudnik-Schoneborn S., Nawroth F. et al. Recurrent miscarriage: diagnostic and therapeutic procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/050). Geburtshilfe Frauenheilkd. 2018; 78(4): 364-81. https://dx.doi.org/10.1055/a-0586-4568.